Tenaya Therapeutics
TNYA
79 hedge funds and large institutions have $280M invested in Tenaya Therapeutics in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 11 reducing their positions, and 6 closing their positions.
687% more call options, than puts
Call options by funds: $732K | Put options by funds: $93K
250% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 6
218% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 11
118% more capital invested
Capital invested by funds: $128M → $280M (+$151M)
23% more funds holding
Funds holding: 64 → 79 (+15)
3.99% more ownership
Funds ownership: 67.28% → 71.26% (+4%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.94M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$3.49M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$2.73M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.89M |
| 5 |
CC
Casdin Capital
New York
|
+$1.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ROTUOC
Regents of the University of California
Oakland,
California
|
-$5.49M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$1.7M |
| 3 |
Renaissance Technologies
New York
|
-$994K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$488K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$155K |
TNYA Hedge Fund Activity: Q2 2023 in Review
79 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q2 2023, worth a combined $280M — up 118% from $128M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new TNYA positions and 6 closed out — a net gain of 15 holders — while 35 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock, adding an estimated $4.94M. The largest seller was Regents of the University of California, cutting an estimated $5.49M.
- 79 institutional investors held Tenaya Therapeutics (TNYA) as of Q2 2023, up from 64 in Q1 2023.
- Funds reported $280M of Tenaya Therapeutics stock for Q2 2023, up 118% quarter-over-quarter.
- 21 funds opened new Tenaya Therapeutics positions in Q2 2023 and 6 closed out, a net change of +15 holders.
- The largest Tenaya Therapeutics buyer in Q2 2023 was BlackRock, an estimated $4.94M added.
- The largest Tenaya Therapeutics seller in Q2 2023 was Regents of the University of California, an estimated $5.49M sold.
Based on aggregated 13F filings for Q2 2023.